Trials / Unknown
UnknownNCT04676776
Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 139 (estimated)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the effectiveness and acceptability of a 3-day missed period pill regimen.
Detailed description
Missed period pills (MPPs) are medications used for uterine evacuation among women with late menses who have not confirmed pregnancy status. Provision of MPPs could expand reproductive service options for individuals in a variety of settings. This study will collect data on the efficacy, safety, and acceptability of a 3-day missed period pill regimen among individuals with missed menses of 1-10 days
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levonorgestrel | All participants receive 1.5 mg levonorgestrel on day 1 |
| DRUG | Mifepristone | All participants receive 200 mg mifepristone on day 3 |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2020-12-21
- Last updated
- 2021-08-12
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04676776. Inclusion in this directory is not an endorsement.